Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No symptoms reported. No additional AE; This case pertains to one patient who received improperly stored VARIVAX on 06/18/2025.; This spontaneous report has been received from a nurse, regarding to patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 18-JUN-2025, the patient was vaccinated with improperly storage of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) at a dose of 0.5 milliliter (ml) (lot #Y015108, expiration date: 06-SEP-2026) plus sterile diluent as prophylaxis (dose, route of administration, and anatomical site of injection were not reported). The administered doses were stored at a temperature of 6.3 degrees Fahrenheit (F) during a time frame of 16 minutes (product storage error). There was no previous temperature excursion. No additional side effects were reported in the patients.
Sterile diluent